The outlook of companies tied to Viagra's legacy presents a challenging investment scenario . While the initial boom generated substantial gains, generic copies have significantly eroded sales . Investing in https://thesocialcircles.com/story7434149/copyright-s-flagship-product-and-the-pharmaceutical-sector-a-risky-investment